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Abstract  
Reactive oxygen species (ROS) are activators of cell signaling and modify 
cellular molecules, including DNA. 8-Oxo-7,8-dihydroguanine (8-oxoG) is one 
of the prominent lesions in oxidatively damaged DNA, whose accumulation is 
causally linked to various diseases and aging processes, whereas its 
etiological relevance is unclear. 8-OxoG is repaired by the 8-oxoguanine DNA 
glycosylase-1 (OGG1)-initiated DNA base excision repair (BER) pathway. 
OGG1 binds free 8-oxoG and this complex functions as an activator of Ras 
family GTPases. Here we examined whether OGG1-initiated BER is associated 
with the activation of Rho GTPase and mediates changes in the cytoskeleton. 
To test this possibility, we induced OGG1- initiated BER in cultured cells and 
mouse lungs and used molecular approaches such as active Rho pull- down 
assays, siRNA ablation of gene expression, immune blotting, and microscopic 
imaging. We found that OGG1 physically interacts with Rho GTPase and, in the 
presence of 8-oxoG base, increases Rho–GTP levels in cultured cells and lungs, 
which mediates α-smooth muscle actin (α-SMA) polymerization into stress 
ﬁbers and increases the level of α-SMA in insoluble cellular/tissue fractions. 
These changes were absent in cells lacking OGG1. These unexpected data and 
those showing that 8-oxoG repair is a lifetime process suggest that, via Rho 
GTPase, OGG1 could be involved in the cytoskeletal changes and organ 
remodeling observed in various chronic diseases. 
Keywords: ROS, OGG1, Base excision repair, Rho–GTP, Cytoskeleton, Free 
radicals 
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Oxidative stress is generated by multiple exogenous agents and 
endogenous sources in mammalian cells.  The resulting reactive oxygen species 
(ROS) cause damage to cellular molecules, includ- ing DNA [1]. In DNA guanine 
is a primary ROS target because it has the lowest reduction potential among the 
nucleic acid bases [2]; 8-oxo-7,8-dihydroguanine (8-oxoG) is thus one of the 
most abundant base lesions. Because of its potential to pair with adenine, 8-
oxoG is also one of the most mutagenic DNA lesions among over 20 identiﬁed 
oxidative modiﬁcations to guanine [3,4]. Accumula- tion of 8-oxoG in DNA has 
been linked to various inﬂammatory diseases, as well as aging processes [5]. The 
oxidatively damaged bases are preferentially repaired by the base excision 
repair (BER) pathway [6,7], which utilizes glycosylases to excise the lesion via 
cleaving its N-glycosidic bond, followed by endonucleolytic cleavage and 
subsequent gap-ﬁlling [6,8]. 
8-Oxoguanine DNA glycosylase-1 (OGG1) is the key enzyme in removing 
8-oxoG and 2,6-diamino-4-hydroxy-5-formamidopyri- midine (FapyG) from 
DNA with equal speciﬁcity and kinetics during BER to prevent mutations and 
maintain genomic integrity [6,9,10]. Surprisingly, Ogg1-knockout (KO) mice 
have no particular phenotype; their life span is unaltered, showing only a 
moderate predisposition to tumorigenesis, despite increased genomic 8-oxoG 
levels [11–13]. A lack of OGG1 activity in KO mice resulted in increased 
resistance to inﬂammation [14], changes in whole-body energy homeostasis, 
increased susceptibility to obesity, and metabolic dysfunction [15]. These results 
suggest additional, not yet deﬁned functions of OGG1 protein and/or its repair 
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product, 8-oxoG. In support of this hypothesis, accumulating data suggest that 
OGG1 may play roles in multiple cellular processes. For example, it has been 
shown that OGG1 colocalizes with centrioles (microtubule organizing centers), 
microtubule networks, and mitotic chromosomes [16,17]. It has also been shown 
that OGG1-generated free 8-oxoG base binds to OGG1 and increases its β-lyase 
activity, mediating product-assisted catalysis in an enzyme-catalyzed reaction 
[18]. Our recent studies also showed that 8-oxoG binds cytoplasmic OGG1, and 
the OGG1 8-oxoG complex acts as a guanine nucleotide exchange factor (GEF) 
catalyzing the exchange of GDP with GTP to promote activation of Ras and 
Rac1 small GTPases [19–21]. 
In response to DNA damage, or in DNA damage-induced senescent cells, 
reorganization of the cytoskeleton, actin ﬁlaments (stress ﬁbers), and ﬁlopodia 
has been observed [22], although the molecular events directly responsible for 
these cytoskeletal mor- phological changes are not yet well deﬁned. Among the 
small GTPase family members, activation of the Ras homology (Rho) proteins 
RhoA, RhoB, and RhoC has been shown to regulate many aspects of intracellular 
actin dynamics, including stress ﬁber formation [23]. Taking into account that 
OGG1 functions as a GEF when complexed with 8-oxoG [19–21], we 
hypothesized that OGG1-BER is associated with Rho activation and transient 
morphological changes in ROS-exposed cells. Here we show that OGG1-initiated 
repair of oxidative DNA damage was followed by an increase in Rho–GTP levels 
and stress ﬁber formation in cultured cells and lung tissues. Thus our studies 
establish a link between repair of oxidatively altered guanine and changes in 
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cellular architecture, placing OGG1 at the center of a complex signaling 
network. 
 
Materials and methods 
 
Materials 
 
8-OxoG (Cat. No. 89290) was from Cayman Chemical Co. (Ann Arbor, MI, USA); 
FapyG was a kind gift from Dr. Miral Dizdaroglu (National Institute of Standards 
and Technology, Gaithersburg, MD, USA); glucose oxidase from Aspergillus niger 
(GOx; Cat. No. G7141-10KU), FITC-conjugated phalloidin (Cat. No. P5282-.1MG), 
trietha- nolamine (TEA; Cat. No. 90279-100ML), and N-TER Nanoparticle siRNA 
Transfection System (Cat.  No. N2913) were from Sigma–Aldrich (St. Louis, MO, 
USA); rabbit polyclonal antibody (Ab) to α-smooth muscle actin (anti-α-SMA; 
Cat. No. ab5694) was from Abcam (Cambridge, MA, USA); monoclonal Abs to 
glyceral-dehyde-3-phosphate dehydrogenase (GAPDH; Cat. No. 2118S) and α-
tubulin (Cat. No. 3873S) were from Cell Signaling Technology (Danvers, MA, 
USA); active Rho pull-down and detection kit (Cat. No. 16116Y) was from 
Thermo Scientiﬁc Pierce Biotechnology (Rockford, IL, USA); OGG1 rabbit 
monoclonal Ab (Cat.  No. 5104-1) was from the Abcam subsidiary Epitomics 
(Burlingame, CA, USA). siGENOME SMARTpool for human OGG1 (Cat.  No. M-
005147-03) was from Dharmacon Thermo Scientiﬁc (Pittsburgh, PA, USA). Rho 
activator (calpeptin, Cat. No. CN01) and Rho inhibitor (C3 transferase, Cat. No. 
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CT04) were from Cytoskeleton (Denver, CO, USA); His-tagged RhoA protein (Cat. 
No. NBP1-50933) was from Novus Biologicals (Littleton, CO, USA); and OGG1 
protein was a kind gift from Dr. Hazra (Department of Biochemistry & 
Molecular Biology, UTMB, Galveston, TX, USA). 2′-(or-3′)-O-(N-
methylanthraniloyl) guanosine 5′-triphosphate (MantGTP) and 2′-(or-3′)-O-
(N-methy- lanthraniloyl) guanosine 5′-diphosphate (MantGDP) were from 
Cytoskeleton. 
 
Cell culture 
 
Human diploid ﬁbroblast (MRC5) and mouse embryonic ﬁbroblast (MEF) cells 
were maintained in Earle's minimum essential medium and Dulbecco's 
modiﬁed Eagle's medium/F-12 (Ham) supplemented with 10% fetal bovine 
serum (FBS), glutamine, penicillin, and streptomycin; cells were grown at 37 
o
C 
in 5% CO2, starved in 0.5% FBS medium for 24 h, and starved in FBS-free medium 
for 16 h before Rho activation. 8-OxoG (10 μM) or GOx (100 ng/ml) was added to 
cells in serum-free medium, and cell extracts were made at the indicated times 
after 8-oxoG or GOx addition. 
 
Animals 
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Animal experiments were performed according to the National Institutes of 
Health guidelines for the use of experimental animals and approved by the 
University of Texas Animal Care and Use Committee (Protocol 0807044A). 
Eight-week-old female BALB/c mice (The Jackson Laboratory, Bar Harbor, ME, 
USA) were challenged intranasally with 1 μM 8-oxoG (60 ml) or an equal volume 
of vehicle and sacriﬁced, and the lungs were excised [24]. In other experiments, 
mice were directly sacriﬁced without treatment. 
 
Histology and immunohistochemistry 
 
For immunochemistry histology staining of α-SMA or F-actin, mice were 
challenged with 1 μM 8-oxoG (in 60 ml phosphate- buffered saline; PBS) and 
sacriﬁced after 30 min. Mouse lungs were ﬁxed, sectioned (4 µm), and stained 
with α-SMA Ab and/or FITC–phalloidin. Cells on chambers slides were 
challenged with the OGG1-initiated BER by-product 8-oxoG for 20 min and 
after treatment ﬁxed with 4% paraformaldehyde for 20 min at room 
temperature, then washed twice with wash buffer (0.05% Tween 20 in PBS), 
and permeabilized with 0.1% Triton X-100 for 3 min. After the wash, blocking 
solution (1% bovine serum albumin in 0.05% Tween 20 in PBS) was added for 
30 min. Mouse anti-rabbit α-SMA monoclonal Ab and FITC–phalloidin were 
diluted in the blocking solution. After 1 h incubation with the primary Ab 
(1:300) followed by three washes with washing buffer, the secondary Ab (goat 
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anti-mouse, FITC-conjugated, dilution 1:500) was added for 30–60 min. Cells 
were washed with 0.05% Tween 20 in PBS three times, dried, and mounted in 
antifade reagent (Cat. No. S3023 from Dako North America, Carpinteria, CA, 
USA). Stress ﬁbers were visualized under a microscope using FITC-conjugated 
phalloidin (50 μg/ml) per the manufacturer's protocol, at 600 x magniﬁcation. 
Each image shown was a typical one in the ﬁeld of view. 
 
Assessment of active Rho levels 
 
Assessment of Rho–GTP levels in cells was conducted using the active Rho pull-
down assay kit as recommended by the manufacturer and described previously 
[19,20]. Brieﬂy, cells were challenged with 100 ng/ml GOx or 10 μM 8-oxoG at 
37 
o
C for the indicated times and lysed in 25 mM Tris–HCl, pH 7.5, 150 mM NaCl, 
60 mM MgCl2, 1% Nonidet P-40, and 5% glycerol, and Rho–GTP in 500 μg extracts 
was captured by the GST–Rho-binding domain of Rhotekin immobilized to 
glutathione resin [25]. After being washed with binding buffer, the activated 
Rho (Rho–GTP) was eluted with Laemmli buffer (0.125 M Tris–HCl, 4% SDS, 20% 
glycerol, 10% 2-mercaptoethanol, pH 6.8) and quantiﬁed by Western blot assay 
using ImageJ 1.46R. 
To assess Rho–GTP levels in the lung lysate, mouse lungs were excised 
and homogenized in lysis buffer provided by the manufacturer (Thermo 
Scientiﬁc Pierce Biotechnology) containing 10 mM EDTA and 60 mM MgCl2. 8-
OxoG (10 μM) was added to 500 μg lung extracts and incubated at 37 o C for the 
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indicated times. In other experiments, mice were challenged intranasally with 
1 μM 8-oxoG (60 ml) for 30 min and sacriﬁced and mouse lungs were 
homogenized. Rho–GTP in 500 μg lung extracts was captured and quantiﬁed by 
Western blot analysis. 
 
Protein–protein binding assays 
 
To determine the interactions between OGG1 and Rho, we conducted His-
afﬁnity pull-down assays as previously described, with slight modiﬁcation [19]. 
Brieﬂy, nickel–nitrilotriacetic acid (Ni–NTA)-agarose beads (Qiagen, Valencia, CA, 
USA) were mixed with His-RhoA protein (6 pmol) in 300 ml of interaction buffer 
(50 mM NaH2PO4, 300 mM NaCl, 20 mM imidazole, 0.05% Tween 20, pH 7.5). After 
a 30-min incubation at 4 
o
C, His-RhoA-bound beads were washed three times, 
and an equimolar amount of OGG1 (6 pmol), alone or plus 8-oxoG (6 pmol), was 
added to the interaction buffer. Samples were incubated for 30 min at 4 
o
C, 
washed twice with interaction buffer, and eluted with Laemmli buffer at 100 
o
C 
for 5 min. The eluents were analyzed on Western blots. 
 
Guanine nucleotide exchange assay 
 
GDP–GTP and GTP–GDP exchange on RhoA was determined by real-time 
ﬂuorescence spectroscopic analysis [21,26]. Speciﬁcally, RhoA (6 pmol) was 
loaded with the nucleotide analog MantGTP or MantGDP in exchange buffer 
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containing 20 mM Tris (pH 7.5), 150 mM NaCl, 1 mM dithiothreitol, 50 mg of bovine 
serum albumin for 30 min. In the case f GDP–GTP exchange, RhoA–MantGDP 
and OGG1 protein (6 pmol) + 8-oxoG base (6 pmol) were mixed with untagged 
GTP. A similar strategy was used to monitor GTP–GDP exchange. Kinetic 
changes in the ﬂuorescence of RhoA–MantGDP or RhoA–MantGTP were 
determined using a POLARstar Omega reader (BMG Labtech, Ortenberg, 
Germany). Curves were ﬁtted using MS Excel. The half-life of RhoA–MantGDP 
was determined using POLARstar Omega software. 
 
Preparation of soluble and insoluble cellular fractions 
 
Cells were lysed in Triton X-100 buffer (50 mM Tris, pH 7.5, 1 mM EDTA, 1 mM 
EGTA, 1 mM Na3VO4, 5 mM sodium pyrophosphate, 10 mM sodium 
glycerophosphate, 1% Triton X-100, 50 mM NaF plus 1% protease inhibitor 
cocktail) and lysates were assayed for protein concentration using the Bradford 
reagent and then diluted with 2 x Laemmli loading buffer for SDS–PAGE. The 
pellets from cell lysates (Triton X-100-insoluble α-SMA pool) were sonicated in 2 
x loading buffer before processing for SDS–PAGE [27]. Equal amounts of protein 
were then loaded onto 4–20% Tris– glycine gels and electrophoresed for 90 min 
at 300 mA constant current. Proteins were blotted onto membranes by 
electrophoretic transfer at 100 V for 1 h at 4 
o
C and α-SMA levels determined by 
Western blotting. 
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Isolation of stress ﬁbers 
 
Cells were cultured for 1 day in 100-mm dishes and starved in 0.5% FBS-
containing medium for 16 h before challenge with 8-oxoG base. Stress ﬁbers 
were isolated as previously described, with slight changes [28].  Brieﬂy, cells 
were washed in ice-cold PBS and then treated with a low-ionic-strength 
extraction solution consisting of 2.5 mM TEA (pH 8.2) with protease inhibitor 
cocktail at 4 
o
C with gentle agitation for 10–40 min, until the dorsal side of the 
cell became free-ﬂoating. Cells were then treated with extraction buffer I 
(0.05% NP-40, 1% protease inhibitor cocktail in PBS, pH 7.2) for 5 min. At this 
stage some cells still had the dorsal side and/or the nucleus, which were then 
removed by gentle shearing under a phase-contrast microscope with a stream 
of extraction buffer I. The material still attached to culture dishes was gently 
washed in extraction buffer II (0.5% Triton X-100, 10% protease inhibitor 
cocktail in PBS, pH 7.2). The extracted material was scraped off from the dish 
and suspended in extraction buffer II, and the crude stress ﬁber isolates were 
suspended in PBS contain- ing protease inhibitor cocktail, pH 7.4) and 
centrifuged at 100,000 g for 1 h. The pellet containing highly concentrated 
stress ﬁbers was sonicated in SDS loading buffer and analyzed by Western blot 
analysis. 
 
SiRNA ablation of gene expression 
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Cells at 60% conﬂuence were transfected with OGG1 siRNA or control siRNA (at 
20 nM, as determined in preliminary studies) using the N-TER Nanoparticle 
siRNA Transfection System. After 24 h, cells were retransfected for another 36 h 
as we described previously [21]. The efﬁciency of OGG1 depletion was 
determined at the protein level by Western blotting. 
 
Statistical analyses 
 
Values are presented as means ± SEM. Statistical comparisons of differences 
were performed using one-way ANOVA combined with t tests; p < 0.05 was 
considered statistically signiﬁcant by Origin 9. 
 
Results 
 
OGG1-BER-associated increases in level of GTP-bound Rho in cultured cells and 
mouse lungs  
 
To test for a link between repair of oxidative DNA damage and the activation of 
Rho GTPases, cells were exposed to GOx, which has been reported to increase 
intracellular ROS levels and oxidative DNA damage [29]. Cell extracts were 
made and Rho–GTP levels were determined by active Rho pull-down assays. 
Our results showed that Rho–GTP levels had bipartite peaks, at 5 min and then 
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at 30 min, in both MRC5 and MEF cells after exposure to GOx (Fig. 1A and B, 
respectively). To examine whether OGG1-BER has a role in Rho activation OGG1 
expression was downregulated, followed by GOx exposure. Intriguingly, 
compared to control we observed no increase in Rho–GTP levels in extracts 
made from OGG1-depleted cells (Fig.  1C), suggesting an important role for 
OGG1-initiated BER and/or OGG1 in oxidative stress-induced Rho activation.  
To examine the impact of OGG1-initiated repair of oxidative DNA 
damage and rule out multiple effects of ROS, we challenged cells with 8-oxoG 
base. Challenging MRC5 and MEF cells with 8-oxoG resulted in activation of Rho 
GTPase (between 2.5 and 20 min; Fig. 1D and E), suggesting that 8-oxoG 
challenge mimics OGG1-initiated repair of oxidatively damaged DNA. OGG1 
excises 8-oxoG and FapyG from DNA with equal speciﬁcity and kinetics [3,4]. 
Therefore, we challenged cells with FapyG. As shown in Fig. 1F, FapyG failed to 
increase GTP-bound levels of Rho, whereas positive 8-oxoG and calpeptin (a 
Rho activator) did so. Similarly, 8-oxo-deoxyguanosine (8-oxodG) failed to 
activate Rho GTPase, in line with its inability to activate Ras and Rac family 
GTPases [19,21]. To determine the percentage of Rho–GTP, autoradiograms were 
quantiﬁed using ImageJ software. In mock-exposed cells the calculated 
percentages of activated Rho were 1.06 and 1.45% (in MRC5 and MEF, 
respectively) upon 8-oxoG treatment; its levels were between 3.8 and 7.3% in 
MRC5 cells (Fig. 1D, bottom) and 2.8 and 8.2% in EF cells (Fig. 1E, bottom). 
Importantly, 8-oxoG- induced increases in Rho–GTP levels were similar to 
those mediated by oxidative stress (GOx) (Fig. 1A and B, bottom). 
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To further examine the role of OGG1 in 8-oxoG-mediated Rho activation, 
cells were depleted of OGG1 by siRNA and then challenged with 8-oxoG. Our 
results showed that a > 80% OGG1 depletion (Fig. 1G, inset) nearly prevented 8-
oxoG exposure-induced Rho activation in MRC5 cells (Fig. 1G). In support, 8-
oxoG challenge rapidly increased Rho–GTP level in Ogg1+/+, but not in Ogg1-/- MEF 
cells (Fig. 1H). 
To test whether Rho is activated in an organ/tissue environment as a 
consequence of OGG1-initiated BER, we challenged mice with 8-oxoG for 30 min 
and active Rho pull-down assays were undertaken. Results in Fig. 1I show 
increased levels of Rho–GTP in individual mouse lungs. Owing to limitations in 
keeping a time course, we generated extracts from unchallenged lungs and 
then added 8-oxoG. Our results showed that adding 8-oxoG base to lung 
extracts induced a rapid increase in GTP-bound Rho levels (Fig. 1J). The 
percentage changes in Rho–GTP in 8-oxoG-treated lung extracts (Fig. 1J, bottom) 
were similar to those observed in cell culture (Fig. 1A, B, D, and E), suggesting 
that in the presence of 8-oxoG base OGG1 in the extracts activates Rho. 
Expression levels of RhoA, RhoB, and RhoC vary signiﬁcantly depending on 
cell/tissue type [30]. Utilizing isotype-speciﬁc Abs, we observed that in both 
MRC5 and MEF cells, RhoA is the most abundant among the three family 
members (Fig. 1K), strongly suggesting that the observed increase in Rho–GTP 
levels is primarily represented by RhoA. Together, these data suggest that Rho 
activation requires OGG1 when cells are exposed to oxidative stress or 8-oxoG, a 
product of OGG1-initiated BER. 
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Interaction of OGG1 with RhoA and GDP GTP exchange 
 
Rho GTPases are inactive when GDP-bound and active when GTP-bound. Cycling 
between these states is controlled by three known classes of regulatory 
proteins: GTPase-activating proteins, guanine nucleotide dissociation inhibitors, 
and GEFs [31]. The rapid OGG1-dependent increase in Rho–GTP levels upon ROS 
or 8-oxoG exposure suggests that OGG1 promotes GDP   GTP exchange and 
may function as a GEF. To examine this possibility we ﬁrst tested interactions 
between OGG1 and RhoA proteins. The results showed that the OGG1 protein 
physically interacts with RhoA (Fig. 2A). Addition of 8-oxoG base did not further 
increase OGG1 binding to RhoA (Fig. 2A). Furthermore, loading of RhoA with GTP 
or GDP had no effect on  OGG1  7 8-oxoG binding to RhoA (Fig. 2B). 
To test whether such binding could contribute to Rho activation, we 
examined the GDP  GTP exchange as previously described [21]. MantGDP's 
ﬂuorescence intensity is 1.33 x 105 ﬂuorescence units (FU). When bound to RhoA, 
the ﬂuorescence intensity was increased to 1.9 x 105 FU. Upon addition of OGG1 
plus 8-oxoG along with unlabeled GTP, the ﬂuorescence intensity of RhoA–
MantGDP rapidly decreased, indicating that the RhoA-bound MantGDP was 
replaced by nonﬂuorescent GTP. Fifty percent of MantGDP was replaced by GTP 
within 60 s. In controls without the 8-oxoG base, OGG1 plus GTP did not change 
RhoA–MantGDP ﬂuorescence. Neither did 8-oxoG base plus GTP, with- out OGG1 
(Fig. 2C). 
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Next, we examined whether OGG1 catalyzes GTP  GDP exchange. Similar to 
MantGDP, the ﬂuorescence intensity of MantGTP was increased (from 1.33 x 
10
5 to 1.9 x 10
5 FU) when bound to RhoA. Upon addition of OGG1 plus 8-oxoG 
along with unlabeled GDP, there was no change in RhoA–MantGTP ﬂuorescence 
intensity, implying the absence of any guanine nucleotide exchange. OGG1 or 8-
oxoG alone caused no change in RhoA–MantGTP ﬂuorescence in the presence of 
GDP (Fig. 2D). Together, these data suggest that OGG1 in complex with 8-oxoG 
functions as a guanine nucleotide exchange factor. 
 
OGG1-BER-associated α-SMA polymerization into stress ﬁbers 
 
To explore the functional consequence of OGG1-BER-mediated activation of 
RhoA in a cellular context, changes in stress ﬁber levels were examined. To do 
so, we utilized serum-starved MRC5 and MEF cells to visualize cytoskeletal 
changes microscopically by using FITC–phalloidin. Microscopic imaging showed 
that in mock- treated cells the bound level of FITC–phalloidin was low. 
Importantly, exposure of cells to 8-oxoG induced obvious changes in the 
cytoskeleton, as shown by the appearance of stress ﬁbers in both MRC5 and 
MEF cells (Fig. 3A). Furthermore, these changes were not observed in OGG1-
knockout cells (Fig. 3A, lowest row), in line with the dependence on OGG1 in the 
8-oxoG-induced increases in Rho–GTP levels (shown in Fig. 1I). As a positive 
control, the Rho activator calpeptin (1 unit/ml) induced formation of stress 
ﬁber in MRC5 cells and MEF (both Ogg1+/+ and Ogg1-/-). In addition to MRC5 and 
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MEF cells, human normal bronchial epithelial cells were also affected by 8-oxoG 
exposure, displaying stress ﬁbers (Fig. 3B). This implies that not only ﬁbroblasts, 
but also epithelial cells, respond to 8-oxoG and possibly to OGG1-initiated repair 
of oxidative DNA damage with cytoskeletal changes. Stress ﬁbers that contain 
α-SMA generate more contractile force than do stress ﬁbers that contain only β- 
and γ-cytoplasmic actin [32]. To test whether α-SMA level was increased in 
ﬁbers, MRC-5 and MEF cells were exposed to 8-oxoG and analyzed by Western 
blotting. Our results showed that from 10 min on, the level of α-SMA was 
increased in  stress ﬁbers in  MRC-5  and MEF cells (Fig. 3C and D), suggesting 
that α-SMA is incorporated into stress ﬁbers in response to 8-oxoG exposure. In 
contrast, there was no obvious increase in α-SMA levels in the stress ﬁbers of 
Ogg1 
-/- 
MEFs in response to 8-oxoG (Fig. 3E). These results support the idea that 
OGG1-dependent Rho activation is the primary reason for α-SMA 
polymerization into stress ﬁbers upon 8-oxoG addition. 
To further explore the importance of OGG1 in activation of Rho and α-
SMA polymerization, OGG1 was depleted from MRC5 cells via siRNA. Cells with 
decreased (~ 80%) OGG1 showed no obvious increase in α-SMA in stress ﬁbers 
after exposure to 8-oxoG (Fig. 3F). To test whether Rho activation is the primary 
cause of stress ﬁber formation by 8-oxoG exposure, we utilized a Rho inhibitor 
(C3 transferase, 2 µg/ml), shown previously to prevent formation of stress 
ﬁbers [33]. Preincubation of cells with C3 transferase signiﬁcantly decreased the 
level of α-SMA in the stress ﬁbers in Ogg1 +/+ MEF cells (Fig. 3G). These data 
strongly suggest that 8-oxoG exposure-induced α-SMA incorporation into 
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stress ﬁbers is OGG1-dependent, linking OGG1-initiated repair of oxidative DNA 
damage to cellular cytoskeletal changes. 
 
Cytoskeletal changes in mouse lungs upon 8-oxoG challenge 
 
Next we examined whether the cytoskeleton was changed in mouse lungs after 
8-oxoG challenge. The lungs were challenged intranasally with 8-oxoG and 
then excised and sectioned (see Materials and methods). Microscopic imaging 
showed an increased colocalization of α-SMA with F-actin in subepithelial regions 
of lung bronchioles (Fig. 4A), suggesting that α-SMA is polymerized into the 
cytoskeleton in response to 8-oxoG. To conﬁrm the incorporation of soluble α-
SMA into stress ﬁbers, lungs were homogenized and the Triton X-100-insoluble 
fractions isolated and subjected to immunoblotting. As shown in Fig. 4B, 8-oxoG 
challenge increased α-SMA levels in the Triton X-100-insoluble cytoskeletal 
fractions of mouse lungs.  
Moreover, this increase was accompanied by a decrease in α-SMA levels in 
the soluble fraction. To validate the method used for this in vivo observation, 
MRC-5 cells were exposed to 8-oxoG and fractionated into Triton X-100-
insoluble/soluble fractions similar to the lung tissue. Immunoblotting showed 
α-SMA redistribution into the insoluble fraction in response to 8-oxoG (Fig. 4C). 
These results imply that α-SMA is incorporated into Triton X-100-insoluble 
cytoskeletal fraction in response to 8-oxoG both in lungs and in cultured cells. 
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Discussion 
 
Supraphysiological levels of 8-oxoG in the genome have been linked to various 
diseases, including malignancies, aging-related neurological diseases, and 
aging processes themselves [34–38]. A common link among these processes is 
change in the actin cytoskeleton, cell–cell interactions, and extracellular 
matrix, and nearly all are thought to be etiologically linked to oxidative stress 
[39]. Here we show that only OGG1-expressing cells showed increased Rho 
activation and α-SMA polymerization into stress ﬁbers in response to oxidative 
stress exposure of cells. Thus our data provide the ﬁrst evidence for an 
association between OGG1-initiated repair of oxidative DNA damage and 
changes in cytoskeleton, which may be one among multiple mechanistic 
explanations for the link between OGG1-BER and aging as well as the 
development of diseases. 
Our present study shows an OGG1 expression-dependent increase in Rho–
GTP level upon oxidative stress exposure. Increases in Rho–GTP levels were 
biphasic; therefore we speculated that the immediate early peak could be due to 
ROS because Rho has a redox-sensitive motif containing two cysteine residues 
(GXXXCGK(S/T)C) in the phosphate-binding loop [40,41], whereas the second 
peak may be a result of OGG1-BER. To pursue the latter hypothesis we 
challenged cells with 8-oxoG, which increased levels of Rho–GTP only in OGG1-
expressing cells, implying that both OGG1 and 8-oxoG base, one of the products 
of OGG1-BER, are important to Rho activation. 
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In theory, activation of Rho GTPases could occur through stimulation of a 
GEF or inhibition of GTPase activating factor; in practice, however, all evidence 
points to GEFs being the most critical mediators of Rho GTPase activation [42]; 
these have the ability to catalyze the exchange of GDP → GTP on Rho GTPases. 
Such actions of GEFs can be measured by their ability to stimulate nucleotide 
exchange in vitro [21]. To obtain initial information on the role of its GEF activity, 
we ﬁrst examined OGG1's ability to bind RhoA in vitro. The OGG1 protein 
physically interacts with Rho protein. Interestingly, interactions between OGG1 
and Rho did not require 8-oxoG base in vitro, which is different from the binding 
of OGG1 to Ras or Rac1 [19,21]. At this time, we have no information on in cellulo 
interactions between OGG1 and RhoA; however, the rapid activation of Rho 
upon OGG1-initiated BER, mimicked by the addition of the OGG1-BER product 
8-oxoG base, strongly suggests their interaction. Furthermore, in the presence 
of 8-oxoG base, OGG1 efﬁciently catalyzed exchange of Rho–MantGDP with 
GTP. These results were not entirely surprising, as OGG1 plus 8-oxoG functions 
as guanine nucleotide release factor for canonical Ras family GTPases [19], 
whereas it has GEF activity for Rac1, as we showed previously [21]. In our 
experiments, substitution of MantGTP for unlabeled GTP was not detectable, 
suggesting that OGG1 primarily catalyzes GDP → GTP exchange. These data are 
consistent with those showing that during guanine nucleotide exchange, GEFs 
interact with GDP-bound GTPases and dissociate GDP at an increased rate, and 
the bound GTP then promotes the release of the GEF from the GTPase  [43,44]. 
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GEFs require posttranslational modiﬁcations to activate Rho GTPases 
[45,46]. In the case of OGG1, its repair product 8-oxoG base was required for GDP 
→  GTP exchange. Indeed, a study showed that OGG1 binds the free 8-oxoG 
base with high afﬁnity (binding constant (Kd) 0.56 ± 0.19 nM) [19]). OGG1's 
binding by 8-oxoG was necessary for activation of Ras and Rac1. It was thus 
unexpected that OGG1's binding by 8-oxoG was not necessary for interaction 
with Rho, but it was essential for Rho guanine nucleotide exchange. These results 
allow us to speculate that Rho-associated OGG1 binds 8-oxoG and then 
mediates GDP → GTP exchange. It has been shown that OGG1 excises not only 
8-oxoG, but also FapyG, from DNA, with equal speciﬁcity and kinetics [4]. In view 
of these facts, we wondered if FapyG exposure of cells increased Rho–GTP levels. 
Results were negative. Lack of Rho activation by FapyG is consistent with data 
showing its undetectable binding to OGG1, which was previously analyzed by 
changes in OGG1's intrinsic tryptophan ﬂuorescence [19]. 
Conventionally, Rho activation modulates the assembly of contractile 
actomyosin stress ﬁbers, Rac–GTP produces lamellipodia and membrane rufﬂes, 
and Cdc42 induces ﬁlopodia formation [30]. To gain insight into the possible 
biological consequences of OGG1-BER-associated Rho activation, we examined 
changes in the α-SMA polymerization into stress ﬁbers, a process primarily 
driven by RhoA–GTP. Our data show that activation of Rho by OGG1-BER, 
mimicked by the addition of 8-oxoG base, resulted in increased stress ﬁber 
content in both MRC5 and MEF ﬁbroblasts, as shown ﬁrst using microscopic 
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imaging. To build upon the imaging data, we showed an OGG1-dependent 
increase in levels of α-SMA in the insoluble cellular fractions. 
ROS-induced signaling pathways are involved in distinct cellular 
biological processes, such as proliferation, cell–cell interactions, cell migration, 
(re)organization of intracellular ﬁlaments, and regulation of the extracellular 
matrix [39]. There is evidence that suitably activated ﬁbroblasts can give rise to a 
differentiated phenotype characterized by the induction of α-SMA, which is 
incorporated into stress ﬁbers, so the cells are aptly identiﬁed as myoﬁbroblasts 
[47]. In our studies we primarily utilized ﬁbroblast cells and carried out in vivo 
experiments, and demonstrated that ROS-induced DNA damage/repair-driven 
Rho activation converts ﬁbroblasts to α-SMA-positive cells, which is one of the 
myoﬁbroblast phenotypes. To circumvent implication of ROS in Rho activation 
and α-SMA polymerization into stress ﬁbers, most of our studies utilized a 
speciﬁc product of OGG1-initiated BER, 8-oxoG base. Our results showing that 
8-oxoG base exposure of cells leads to increased Rho–GTP levels raise the 
possibility that OGG1-BER is coupled to cellular morphological changes and the 
regulation of the cytoskeleton via Rho in oxidatively stressed cells. To test 
whether OGG1-BER and release of 8-oxoG are key events in Rho activation and 
changes in cytoskeleton, OGG1-initiated BER was prevented using siRNA 
speciﬁc for OGG1. As expected, ablation of OGG1 signiﬁcantly decreased Rho 
activation in both oxidatively stressed and 8-oxoG-challenged cells. 
In our studies, we utilized experimental animals to show the translational 
signiﬁcance of our studies. Our rationale for using the lungs was that they 
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directly interact with the environment and are exposed to pollutants, resulting 
in oxidative stress and consequently DNA damage [48], including guanine 
oxidation, which is subject to repair via OGG1-BER. In addition, major age- and 
occupation-related chronic airway diseases (e.g., asthma and COPD) are 
associated with tissue remodeling, which is thought to be related to an 
increased oxidative state and DNA damage [49]. In 8-oxoG base-challenged 
mouse lungs RhoA was activated; consequently α-SMA was polymerized into 
the cytoskeleton and accumulated in insoluble fractions. Thus our data may give 
us a clue to a mechanism by which  ROS-induced DNA damage and OGG1-
initiated repair of oxidative DNA damage play roles in lung remodeling, and 
ﬁbrosis, including idiopathic pulmonary ﬁbrosis. These cellular pathological 
changes are usually linked to decreased DNA repair, including OGG1-BER. 
Interestingly, our ﬁndings show the opposite, the involvement of OGG1-intiated 
BER in cytoskeletal changes. One may propose that oxidative stress, generation 
of DNA base damage, and the consequent DNA repair by OGG1 could be 
involved in organ/tissue remodeling observed in various chronic diseases or 
aging-associated processes. Although it should be proven experimentally, we 
speculate that decreased OGG1 activity observed in ﬁbrotic tissues and 
malignant cells, for example, could be a cellular defense against extensive 
cellular cytoskeletal changes that are required for the proliferation and 
migration of cancerous cells. 
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Fig. 1. Activation of Rho GTPase coincides with OGG1-initiated BER. (A, B) Increased Rho–
GTP levels in cultured cells exposed to oxidative stress. (A) MRC-5 and (B) MEF cells were 
exposed to GOx (100 ng/ml) and lysed at the times indicated. Rho–GTP levels were 
determined in 500 μg cell extracts by active Rho pull-down assays. (C) OGG1 depletion 
decreased Rho activation. MRC5 cells were transfected with siRNA to OGG1 or control siRNA 
and exposed to GO for 5 min. Rho–GTP was determined as for (A) and (B). (D, E) The OGG1-
BER product 8-oxoG base increases Rho–GTP levels. (D) MRC5 and (E) MEF cells were 
exposed to 8-oxoG (10 µM) at 37 oC, cell extracts prepared at the indicated times, and Rho–
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GTP levels determined as for (A) and (B). (F) Lack of Rho activation in FapyG-exposed cells. 
Cells  were exposed to FapyG (10 µM) and cell extracts were prepared at 5 min and Rho–
GTP levels determined as for (A) and (B). As controls, calpeptin (a Rho activator) and 8-
oxodG were used. (G) OGG1 depletion prevents Rho activation in 8-oxoG-exposed cells. 
MRC5 cells were transfected with OGG1 or control siRNA and exposed to 8-oxoG for 5 min. 
Rho–GTP was determined as for (A) and (B). Inset: extent of OGG1 downregulation by siRNA. 
(H) Lack of 8-oxoG-induced Rho activation in Ogg-/-
 
MEFs. Cells (Ogg1-/- and Ogg1+/+) were 
challenged with 8-oxoG, extracts were made at 5 min, and changes in Rho–GTP levels 
were determined by pull-down assays as for (A) and (B). (I) Activation of Rho GTPase in 
mouse lungs. Mice were challenged with 8-oxoG (1 mM) via the intranasal route and at 30 
min active Rho was determined by pull-down assays. (J) Activation of Rho in lung extracts 
by 8-oxoG. Lung extracts from unchallenged mice were incubated with 10 mM 8-oxoG as 
indicated and changes in Rho–GTP levels determined as for (A) and (B). The graphs in (A), 
(B), (D), (E), and (J) depict the % of activated Rho. Band intensities were analyzed with 
ImageJ software and the percentage of active Rho in total Rho was calculated. (K) Expression 
of Rho isotypes in MRC-5 and Ogg1-/- and Ogg1+/+ MEF cells. Cell extracts (20 μg) were 
subjected to SDS–PAGE and RhoA, B, and C levels were determined by immunoblotting 
using type-speciﬁc Abs.  GAPDH levels show equal loading. Cont, control. MEF, mouse 
embryonic ﬁbroblasts; MRC5, human embryonic lung ﬁbroblasts. Each experiment was 
repeated at least three times. *p < 0.05, **p  < 0.01. 
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Fig. 2. Interaction of OGG1 with RhoA protein and guanine nucleotide exchange in the 
presence of 8-oxoG base. (A) Physical interaction of OGG1 protein with RhoA. His-RhoA (6 
pmol) bound to Ni–NTA was incubated with OGG1 protein (6 pmol) for 30 min ± 8-oxoG 
(6 pmol). OGG1 binding to Rho was detected by Western blot analysis. (B) Physical 
interaction of OGG1 protein with RhoA in the presence of GDP, GTP, and/or 8-oxoG was 
detected as described for (A). (C) Exchange of RhoA-bound GDP to GTP by OGG1 in the 
presence of the 8-oxoG base. RhoA protein (6 pmol) was loaded with MantGDP (6 pmol) 
and nucleotide exchange was initiated by adding OGG1 + 8-oxoG and GTP (6 pmol) (■). 
The controls, RhoA–MantGDP + GTP + OGG1, RhoA–MantGDP + GTP + 8-oxoG, or 
MantGDP + GTP + OGG1 +  8-oxoG, did not catalyze RhoA–GTP  GDP exchange. (D) OGG1 
does not catalyze RhoA–GTP  GDP exchange. RhoA loaded with MantGTP was incubated 
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with GDP + OGG1 + 8-oxoG, GDP + 8-oxoG, or GDP + OGG1. The control was MantGTP with 
GDP + OGG1 + 8-oxoG. In (C) and (D), changes in the ﬂuorescence of RhoA–MantGDP and 
RhoA–MantGTP were determined by real-time measurements using a POLARstar Omega 
(BMG Labtech). Curves were ﬁtted using MS Excel, n  3–5. 
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Fig. 3. α-SMA polymerization into stress ﬁbers in OGG1-expressing cells. (A) MRC5 and MEF 
cells and (B) hNBECs were challenged with 8-oxoG (10 mM) for 20 min, ﬁxed, and stained 
with FITC–phalloidin. Representative images were taken using a Nikon Eclipse Ti 
microscope system ( x 192 original magniﬁcation). As a positive control, cells were 
incubated with the Rho activator calpeptin (1 unit/ml) for 20 min. (C–E) Cells were treated 
with 8-oxoG (10 mM) for the indicated times and insoluble fractions were isolated as 
described under Materials and methods. α-SMA polymerized into stress ﬁbers was 
detected by Western blot analysis. (F) MRC5 cells were transfected with OGG1-speciﬁc or 
control siRNA as described under Materials and methods, and α-SMA in stress ﬁbers was 
examined 20 min after challenge with 8-oxoG. (G) MRC5 cells were incubated with the 
Rho inhibitor C3 transferase (2 µg/ml) for 4 h before a 20-min 8-oxoG challenge. Insoluble 
fractions were isolated and α-SMA in the isolated fractions was analyzed by Western 
blotting. SF-α-SMA, α-SMA in the stress ﬁbers; Cont, control; hNBEC, human normal 
bronchial epithelial cell; FITC, ﬂuorescein isothiocyanate. Each experiment was repeated 
at least three times. 
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Fig. 4. 8-OxoG base-induced α-SMA polymerization in lungs. (A) Lungs were 8-oxoG (1 
mM)-challenged and excised 30 min thereafter, ﬁxed, sectioned, and stained with 
antibody to α-SMA (red) and F-actin (green). Images were taken using a Nikon Eclipse Ti 
microscope system ( x 138 original magniﬁcation). (B) Lungs were excised and the 
trachea and bronchial branches removed and homogenized in cytoskeleton lysis buffer. 
Triton X-100-insoluble (cytoskeletal) and soluble fractions were subjected to PAGE. α-SMA 
(and α-tubulin and GAPDH  used as  loading controls) was detected using speciﬁc 
antibodies. (C) MRC5 cells were exposed to 8-oxoG (10 mM) for 20 min and Triton X-100-
insoluble and soluble fractions were analyzed as for (B). Cont, control. Each experiment 
was repeated at least three times. 
 
